Mixed Depression in Bipolar Disorder: Prevalence Rate and Clinical Correlates During Naturalistic Follow-Up in the Stanley Bipolar Network
Overview
Authors
Affiliations
Objective: DSM-5 introduced the "with mixed features" specifier for major depressive episodes. The authors assessed the prevalence and phenomenology of mixed depression among bipolar disorder patients and qualitatively compared a range of diagnostic thresholds for mixed depression.
Method: In a naturalistic study, 907 adult outpatients with bipolar disorder participating in the Stanley Foundation Bipolar Network were followed longitudinally across 14,310 visits from 1995 to 2002. The Inventory of Depressive Symptomatology-Clinician-Rated Version (IDS-C) and the Young Mania Rating Scale (YMRS) were administered at each visit.
Results: Mixed depression, defined as an IDS-C score ≥15 and a YMRS score >2 and <12 at the same visit, was observed in 2,139 visits (14.9% of total visits, and 43.5% of visits with depression) by 584 patients (64.4% of all patients). Women were significantly more likely than men to experience subthreshold hypomania during visits with depression (40.7% compared with 34.4%). Patients with one or more mixed depression visits had more symptomatic visits and fewer euthymic visits compared with those with no mixed depression visits. DSM-5-based definitions of mixed depression (ranging from narrower definitions requiring ≥3 nonoverlapping YMRS items concurrent with an IDS-C score ≥15, to broader definitions requiring ≥2 nonoverlapping YMRS items) yielded lower mixed depression prevalence rates (6.3% and 10.8% of visits, respectively) but were found to have similar relationships to gender and longitudinal symptom severity.
Conclusions: Among outpatients with bipolar disorder, concurrent hypomanic symptoms observed during visits with depression were common, particularly in women. The DSM-5 diagnostic criteria for depression with mixed features may yield inadequate sensitivity to detect patients with mixed depression.
Tundo A, Musetti L, Betro S, Cambiali E, de Filippis R, Marazziti D Eur Psychiatry. 2023; 66(1):e75.
PMID: 37697671 PMC: 10594275. DOI: 10.1192/j.eurpsy.2023.2445.
Grover S, Sahoo S, Mishra K, Deep R, Nebhinani N, Bhattacharya R Indian J Psychiatry. 2023; 65(6):671-679.
PMID: 37485405 PMC: 10358806. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_113_23.
Tavares D, Suen P, Moreno D, Vieta E, Moreno R, Brunoni A Braz J Psychiatry. 2022; 44(6):576-583.
PMID: 36580584 PMC: 9851764. DOI: 10.47626/1516-4446-2022-2606.
Apicella M, Serra G, Iannoni M, Trasolini M, Maglio G, Andracchio E Curr Neuropharmacol. 2022; 21(6):1343-1354.
PMID: 36237159 PMC: 10324339. DOI: 10.2174/1570159X20666221012113458.
Electroconvulsive therapy following incident bipolar disorder: When, how, and for whom?.
Salagre E, Rohde C, Vieta E, Ostergaard S Bipolar Disord. 2022; 24(8):817-825.
PMID: 36064283 PMC: 10087321. DOI: 10.1111/bdi.13254.